WASHINGTON, June 21 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry recently completed another successful showcase of its Unified eClinical Solution at the annual DIA show. DATATRAK's premier Solution coupled with the DATATRAK ONE™ business model are hallmarks of its singular technological vision and unwavering commitment to customers. As evidenced by the warm reception at DIA, the Company is well positioned to make a significant impact on the market.
"We were impressed with the knowledge and sophistication of those that visited us at the show. The industry is no longer satisfied with a stand-alone EDC offering but a fully functioning clinical solution -- which we have. This allows us to provide solutions to specific and complex clinical challenges not addressed by their current system." said Laurence P. Birch, DATATRAK's Chairman of the Board. He continued, "Customers, prospects and even our competitors are validating a unified solution as the best approach because it enhances the safety, simplicity and speed of clinical trials allowing customers to obtain high quality data more efficiently while simultaneously lowering costs."
During the past year, the five-year old unified DATATRAK eClinical™ platform further evolved to seamlessly incorporate more than 200 new customer requested features, and DATATRAK revitalized its professional services offerings as DATATRAK ONE™, a unified approach to clinical support centered on its eClinical platform. At DIA, a captive audience viewed demonstrations of a few of these new features such as: expanded libraries, enhanced import and export tools, state of the art workflow, and a new safety case management offering.
As DATATRAK closed out the 46th annual DIA show, it looks forward to increasing sales, enhancing backlog, profitability and a balance sheet free of debt while harnessing the momentum of DATATRAK ONE™ on clinical development. The market is beginning to see a quantifiable difference between a truly unified solution and the traditional integrated software approach on their overall clinical development costs, not just their technology costs. Even more important is the integrity of data which may be subject to scrutiny when derived from an integrated system. As a leading choice for clinical trials along with a strong Partner Network, DATATRAK ONE™ delivers the solution to the industry's need for safety, simplicity and speed.
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery in DATATRAK ONE™, the seamless delivery of product and services. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK eClinical™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, has successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK has offices located in Cleveland, Ohio, and Bryan, Texas. For more information, visit http://www.datatrak.net.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the Pink OTC Markets on May 12, 2010 announcing its results for the three month period ending March 31, 2010. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.